↓ Skip to main content

Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review

Overview of attention for article published in Cochrane database of systematic reviews, September 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
130 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review
Published in
Cochrane database of systematic reviews, September 2012
DOI 10.1002/14651858.cd001901.pub2
Pubmed ID
Authors

Gashirai K Mbizvo, Pete Dixon, Jane L Hutton, Anthony G Marson

Abstract

Epilepsy is an important neurological condition and drug resistance in epilepsy is particularly common in individuals with focal seizures. In this review, we summarise the current evidence regarding a new antiepileptic drug, levetiracetam, when used as add-on treatment for controlling drug-resistant focal epilepsy. This is an update to a Cochrane Review that was originally published in 2001.

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Italy 2 2%
United Kingdom 1 <1%
Canada 1 <1%
Germany 1 <1%
Unknown 123 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 23%
Researcher 17 13%
Student > Postgraduate 12 9%
Student > Bachelor 12 9%
Student > Ph. D. Student 11 8%
Other 36 28%
Unknown 12 9%
Readers by discipline Count As %
Medicine and Dentistry 58 45%
Nursing and Health Professions 11 8%
Psychology 10 8%
Unspecified 6 5%
Social Sciences 5 4%
Other 20 15%
Unknown 20 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2017.
All research outputs
#3,177,148
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#5,471
of 8,923 outputs
Outputs of similar age
#33,154
of 142,606 outputs
Outputs of similar age from Cochrane database of systematic reviews
#32
of 80 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 142,606 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.